|
1
|
Wei KR, Zheng RS, Zhang SW, Liang ZH, Li
ZM and Chen WQ: Nasopharyngeal carcinoma incidence and mortality in
China, 2013. Chin J Cancer. 36:902017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang W, Guo Q, Liu G, Zheng F, Chen J,
Huang D, Ding L, Yang X, Song E, Xiang Y and Yao H: NKILA represses
nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB
pathway inhibition. PLoS Genet. 15:e10083252019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Razak AR, Siu LL, Liu FF, Ito E,
O'Sullivan B and Chan K: Nasopharyngeal carcinoma: The next
challenges. Eur J Cancer. 46:1967–1978. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cao C, Zhou S and Hu J: Long noncoding RNA
MAGI2-AS3/miR-218-5p/GDPD5/SEC61A1 axis drives cellular
proliferation and migration and confers cisplatin resistance in
nasopharyngeal carcinoma. Int Forum Allergy Rhinol. 10:1012–1023.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Young LS and Dawson CW: Epstein-Barr virus
and nasopharyngeal carcinoma. Chin J Cancer. 33:581–590.
2014.PubMed/NCBI
|
|
6
|
Zhao CX, Zhu W, Ba ZQ, Xu HJ, Liu WD, Zhu
B, Wang L, Song YJ, Yuan S and Ren CP: The regulatory network of
nasopharyngeal carcinoma metastasis with a focus on EBV, lncRNAs
and miRNAs. Am J Cancer Res. 8:2185–2209. 2018.PubMed/NCBI
|
|
7
|
Wang Y, Chen W, Lian J, Zhang H, Yu B,
Zhang M, Wei F, Wu J, Jiang J, Jia Y, et al: The lncRNA PVT1
regulates nasopharyngeal carcinoma cell proliferation via
activating the KAT2A acetyltransferase and stabilizing HIF-1α. Cell
Death Differ. 27:695–710. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng ZQ, Li ZX, Zhou GQ, Lin L, Zhang LL,
Lv JW, Huang XD, Liu RQ, Chen F, He XJ, et al: Long noncoding RNA
FAM225A promotes nasopharyngeal carcinoma tumorigenesis and
metastasis by acting as ceRNA to sponge miR-590-3p/miR-1275 and
upregulate ITGB3. Cancer Res. 79:4612–4626. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lou T, Ke K, Zhang L, Miao C and Liu Y:
LncRNA PART1 facilitates the malignant progression of colorectal
cancer via miR-150-5p/LRG1 axis. J Cell Biochem. 121:4271–4281.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen
X, Zhang Q, Yan G and Cui Q: LncRNADisease: A database for
long-non-coding RNA-associated diseases. Nucleic Acids Res.
41((Database Issue)): D983–D986. 2013.PubMed/NCBI
|
|
11
|
Wang M, Ji YQ, Song ZB, Ma XX, Zou YY and
Li XS: Knockdown of lncRNA ZFAS1 inhibits progression of
nasopharyngeal carcinoma by sponging miR-135a. Neoplasma.
66:939–945. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang E and Li X: LncRNA SOX2-OT regulates
proliferation and metastasis of nasopharyngeal carcinoma cells
through miR-146b-5p/HNRNPA2B1 pathway. J Cell Biochem.
120:16575–16588. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu D, Wang Y, Zhao Y and Gu X: LncRNA
SNHG5 promotes nasopharyngeal carcinoma progression by regulating
miR-1179/HMGB3 axis. BMC Cancer. 20:1782020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang B, Jia L, Ren H, Jin C, Ren Q, Zhang
H, Hu D, Zhang H, Hu L and Xie T: LncRNA DLX6-AS1 increases the
expression of HIF-1α and promotes the malignant phenotypes of
nasopharyngeal carcinoma cells via targeting MiR-199a-5p. Mol Genet
Genomic Med. 8:e10172020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shen B, Yuan Y, Zhang Y, Yu S, Peng W,
Huang X and Feng J: Long non-coding RNA FBXL19-AS1 plays oncogenic
role in colorectal cancer by sponging miR-203. Biochem Biophys Res
Commun. 488:67–73. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang Q, Cheng L, Ma D and Zhao Y:
FBXL19-AS1 exerts oncogenic function by sponging miR-431-5p to
regulate RAF1 expression in lung cancer. Biosci Rep.
39:BSR201818042019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Xiao X, Zhou W, Hu J and Zhou D:
LIN28A-stabilized FBXL19-AS1 promotes breast cancer migration,
invasion and EMT by regulating WDR66. In Vitro Cell Dev Biol Anim.
55:426–435. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fromm B, Billipp T, Peck LE, Johansen M,
Tarver JE, King BL, Newcomb JM, Sempere LF, Flatmark K, Hovig E and
Peterson KJ: A uniform system for the annotation of vertebrate
microRNA Genes and the evolution of the human microRNAome. Annu Rev
Genet. 49:213–242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rong X, Gao W, Yang X and Guo J:
Downregulation of hsa_circ_0007534 restricts the proliferation and
invasion of cervical cancer through regulating miR-498/BMI-1
signaling. Life Sci. 235:1167852019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fridrichova I and Zmetakova I: MicroRNAs
contribute to breast cancer invasiveness. Cells. 8:13612019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aghajani M, Mansoori B, Mohammadi A,
Asadzadeh Z and Baradaran B: New emerging roles of CD133 in cancer
stem cell: Signaling pathway and miRNA regulation. J Cell Physiol.
234:21642–21661. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yin W, Shi L and Mao Y: MicroRNA-449b-5p
suppresses cell proliferation, migration and invasion by targeting
TPD52 in nasopharyngeal carcinoma. J Biochem. 166:433–440. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang T, Du M, Zhang W, Bai H, Yin L, Chen
W, He X and Chen Q: MicroRNA-432 suppresses invasion and migration
via E2F3 in nasopharyngeal carcinoma. Onco Targets Ther.
12:11271–11280. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He W, Huang Y, Jiang CC, Zhu Y, Wang L,
Zhang W, Huang W, Zhou T and Tang S: miR-100 inhibits cell growth
and proliferation by targeting HOXA1 in nasopharyngeal carcinoma.
Onco Targets Ther. 13:593–602. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yin D, Wei G, Yang F and Sun X: Circular
RNA has circ 0001591 promoted cell proliferation and metastasis of
human melanoma via ROCK1/PI3K/AKT by targeting miR-431-5p. Hum Exp
Toxicol. 40:310–324. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li MF, Li YH, He YH, Wang Q, Zhang Y, Li
XF, Meng XM, Huang C and Li J: Emerging roles of hsa_circ_0005075
targeting miR-431 in the progress of HCC. Biomed Pharmacother.
99:848–858. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Y, Li L, Liu Z, Yuan Q and Lu X:
Downregulation of miR-431 expression associated with lymph node
metastasis and promotes cell invasion in papillary thyroid
carcinoma. Cancer Biomark. 22:727–732. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Y, Qian W, Feng F, Cao Q, Li Y, Hou
Y, Zhang L and Fan J: Upregulated lncRNA CASC2 may inhibit
malignant melanoma development through regulating miR-18a-5p/RUNX1.
Oncol Res. 27:371–377. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gao W, Lin S, Cheng C, Zhu A, Hu Y, Shi Z,
Zhang X and Hong Z: Long non-coding RNA CASC2 regulates Sprouty2
via functioning as a competing endogenous RNA for miR-183 to
modulate the sensitivity of prostate cancer cells to docetaxel.
Arch Biochem Biophys. 665:69–78. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu D, Gong H, Tao Z, Chen S, Kong Y and
Xiao B: LncRNA IUR downregulates miR-144 to regulate PTEN in
nasopharyngeal carcinoma. Arch Physiol Biochem. Aug 14–2020.(Epub
ahead of print). View Article : Google Scholar
|
|
32
|
Tang T, Yang L, Cao Y, Wang M, Zhang S,
Gong Z, Xiong F, He Y, Zhou Y, Liao Q, et al: LncRNA AATBC
regulates Pinin to promote metastasis in nasopharyngeal carcinoma.
Mol Oncol. 14:2251–2270. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dong G, Pan T, Zhou D, Li C, Liu J and
Zhang J: FBXL19-AS1 promotes cell proliferation and inhibits cell
apoptosis via miR-876-5p/FOXM1 axis in breast cancer. Acta Biochim
Biophys Sin (Shanghai). 51:1106–1113. 2019.PubMed/NCBI
|
|
34
|
Wang L, Zhang X, Liu Y and Xu S: Long
noncoding RNA FBXL19-AS1 induces tumor growth and metastasis by
sponging miR-203a-3p in lung adenocarcinoma. J Cell Physiol.
235:3612–3625. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang J, Qiu Q, Qian X, Yi J, Jiao Y, Yu M,
Li X, Li J, Mi C, Zhang J, et al: Long noncoding RNA LCAT1
functions as a ceRNA to regulate RAC1 function by sponging
miR-4715-5p in lung cancer. Mol Cancer. 18:1712019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Thomson DW and Dinger ME: Endogenous
microRNA sponges: Evidence and controversy. Nat Rev Genet.
17:272–283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cui M, Chang Y, Fang QG, Du W, Wu JF, Wang
JH, Liu ST and Luo SX: Non-Coding RNA Pvt1 promotes cancer stem
cell-like traits in nasopharyngeal cancer via inhibiting miR-1207.
Pathol Oncol Res. 25:1411–1422. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen X, Huang Y, Shi D, Nie C, Luo Y, Guo
L, Zou Y and Xie C: LncRNA ZNF667-AS1 promotes ABLIM1 expression by
adsorbing micro RNA-1290 to suppress nasopharyngeal carcinoma cell
progression. Onco Targets Ther. 13:4397–4409. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yao H, Yang L, Tian L, Guo Y and Li Y:
LncRNA MSC-AS1 aggravates nasopharyngeal carcinoma progression by
targeting miR-524-5p/nuclear receptor subfamily 4 group A member 2
(NR4A2). Cancer Cell Int. 20:1382020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang W, Dong Y, Li X, Pan Y, Du J and Liu
D: MicroRNA-431 serves as a tumor inhibitor in breast cancer
through targeting FGF9. Oncol Lett. 19:1001–1007. 2020.PubMed/NCBI
|
|
41
|
Huang W, Zeng C, Hu S, Wang L and Liu J:
ATG3, a Target of miR-431-5p, promotes proliferation and invasion
of colon cancer via promoting autophagy. Cancer Manag Res.
11:10275–10285. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
An G, Ng AY, Meka CS, Luo G, Bright SP,
Cazares L, Wright GL Jr and Veltri RW: Cloning and characterization
of UROC28, a novel gene overexpressed in prostate, breast, and
bladder cancers. Cancer Res. 60:7014–7020. 2000.PubMed/NCBI
|
|
43
|
Pan T, Wu R, Liu B, Wen H, Tu Z, Guo J,
Yang J and Shen G: PBOV1 promotes prostate cancer proliferation by
promoting G1/S transition. Onco Targets Ther. 9:787–795. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Guo Y, Wu Z, Shen S, Guo R, Wang J, Wang
W, Zhao K, Kuang M and Shuai X: Nanomedicines reveal how PBOV1
promotes hepatocellular carcinoma for effective gene therapy. Nat
Commun. 9:34302018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Carleton NM, Zhu G, Gorbounov M, Miller
MC, Pienta KJ, Resar LMS and Veltri RW: PBOV1 as a potential
biomarker for more advanced prostate cancer based on protein and
digital histomorphometric analysis. Prostate. 78:547–559. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu Z, Wu K, Wu J, Tian D, Chen Y, Yang Z
and Wu A: NEAT1 is a potential prognostic biomarker for patients
with nasopharyngeal carcinoma. J Cell Biochem. 120:9831–9838. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yao L, Wang T and Wang X: LncRNA FOXP4-AS1
serves as a biomarker for nasopharyngeal carcinoma diagnosis and
prognosis. 3 Biotech. 11:252021. View Article : Google Scholar : PubMed/NCBI
|
